本页面由Tiger Trade Technology Pte. Ltd.提供服务

Petros Pharmaceuticals, Inc.

0.0068
+0.000813.60%
成交量:50.92万
成交额:3,852.65
市值:28.81万
市盈率:0.00
高:0.0082
开:0.0060
低:0.0060
收:0.0060
52周最高:2.62
52周最低:0.0017
股本:4,237.23万
流通股本:4,228.91万
量比:4.04
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-3.2061
每股收益(LYR):-83.4693
净资产收益率:-565.29%
总资产收益率:-48.91%
市净率:0.09
市盈率(LYR):0.00

数据加载中...

2025/02/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/13

SEC问询函

Form CORRESP - Correspondence
2025/02/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/12

SEC问询函

Form CORRESP - Correspondence
2025/02/11

SEC问询函

Form CORRESP - Correspondence
2025/02/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/24

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/01/24

重要事件披露

Form 8-K - Current report
2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/18

重要事件披露

Form 8-K - Current report
2024/10/17

重要事件披露

Form 8-K - Current report
2024/10/04

重要事件披露

Form 8-K - Current report
2024/09/19

重要事件披露

Form 8-K - Current report
2024/08/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/31

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/17

SEC问询函

Form CORRESP - Correspondence